Oncotarget Epigenetics and Immunotherapy Combined Fights Rare Lymphoma In a new Oncotarget study, researchers assessed an epigenetic and immunotherapy treatment regimen among patients... read more August 24, 2022
Oncotarget New Analogs of Mibefradil Created as Radiosensitizers for Glioblastoma Researchers from Yale University conducted a study to create mibefradil analogs as superior radiosensitizers in... read more April 28, 2021
Oncotarget STUDY FINDS CANCER DRUG PRICING VARIES WIDELY BY GLOBAL DIFFERENCES IN WEALTH Drugpricing is a big issue in the news, and there is continued controversysurrounding... read more June 10, 2020